As the COVID-19 pandemic continues, recent editorials published by Feinberg faculty explore COVID-19 and its impact on medicine, including potential drug targets and the need for more clinical trials to maximizing trainee education.
Asaf Bitton, MD, delivered an Institute for Global Health Seminar Series lecture on the importance of primary care in health systems around the world.
After a stint at the Department of Health and Human Services, Ariel Thames, a third-year MSTP student, is working to do the most good by using her policy knowledge and scientific acumen to channel research discoveries into effective treatments.
A new study has found no evidence that the 2019 novel coronavirus, COVID-19, is passed from women in their third trimester to the fetus in the womb.
Second-year student Salem Argaw’s research found that the Trump Administration’s Public Charge Rule would pose harm on immigrants in Cook County. Her findings helped persuade a federal judge in Chicago to issue a temporary injunction to stop the rule.
Archit Bharathwaj Baskaran, a second-year student, envisions using healthcare to change society for the better, through leadership and service with student and non-profit groups during his time at Feinberg.
Kamya Bijawat, a second-year medical student, spent a month this summer in South Africa studying how wireless infant monitoring sensors developed at Northwestern could improve parent-infant bonding in low-resource settings.
Feinberg’s new Institute for Global Health hosted its inaugural Global Health Day symposium, a day-long event that featured presentations from each of the institute’s constituent Centers, a poster session, several panels and keynote speakers.
A Northwestern Medicine study found that almost 30 percent of healthcare professionals and trainees from high-income countries have performed outside their scope of training while working or volunteering in low- and middle-income countries.
A new machine-learning tool demonstrates the clinical potential of ‘junk DNA’ methylation in hepatitis C-associated liver cancer patients without the need for expensive testing.